.png)
Prostate Cancer Market by Type and Distribution Channel- Global Industry Analysis & Forecast to 2027
Published On : September 2020 Pages : 157 Category: Pharma & Healthcare Report Code : HC0912745
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Prostate Cancer Market By Type (Benign Prostatic Hyperplasia, Prostatic Adenocarcinoma, Small Cell Carcinoma, Other Types) and Distribution Channel (Hospital pharmacies, drug stores amp; retail pharmacies, and online pharmacies) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Prostate Cancer Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Prostate Cancer is the growth of cells in the prostate gland and is the most common type of cancer found in men prostate that produces and stores fluid and helps to make semen. Prostate Cancer Program offers a broad range of innovative diagnostic and treatment options to patients who have been diagnosed with prostate cancer.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Prostate Cancer Marketsize market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Bayer AG
- Johnson & Johnson
- Ipsen Group
- Amgen, Inc.
- Endo Pharmaceuticals, Inc.
- AbbVie, Inc.
- Pfizer, Inc.
- AstraZeneca
- Sanofi
- Sanpower Group
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Prostate Cancer, ByType, Estimates and Forecast, 2017-2027 ($Million)
o Benign Prostatic Hyperplasia
o Prostatic Adenocarcinoma
o Small Cell Carcinoma
o Other Types
· Prostate Cancer, ByDistribution Channel, Estimates and Forecast, 2017-2027 ($Million)
o Hospital pharmacies
o Drug stores amp
o Retail pharmacies
o Online pharmacies
· Prostate Cancer, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Bayer AG
o Johnson & Johnson
o Ipsen Group
o Amgen, Inc.
o Endo Pharmaceuticals, Inc.
o AbbVie, Inc.
o Pfizer, Inc.
o AstraZeneca
o Sanofi
o Sanpower Group
· Prostate Cancer, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Prostate Cancer , By Country
o U.S. Prostate Cancer
o Canada Prostate Cancer
o Mexico Prostate Cancer
o Europe
§ Europe Prostate Cancer , By Country
o UK Prostate Cancer
o Germany Prostate Cancer
o France Prostate Cancer
o Russia Prostate Cancer
o Italy Prostate Cancer
o Rest of Europe Prostate Cancer
o Asia-Pacific
§ Asia-Pacific Prostate Cancer , By Country
o China Prostate Cancer
o Japan Prostate Cancer
o South Korea Prostate Cancer
o India Prostate Cancer
o Southeast Asia Prostate Cancer
o Rest of Asia-Pacific Prostate Cancer
o South America
§ South America Prostate Cancer
o Brazil Prostate Cancer
o Argentina Prostate Cancer
o Columbia Prostate Cancer
o Rest of South America Prostate Cancer
o Middle East and Africa
§ Middle East and Africa Prostate Cancer
o Saudi Arabia Prostate Cancer
o UAE Prostate Cancer
o Egypt Prostate Cancer
o Nigeria Prostate Cancer
o South Africa Prostate Cancer
o Rest of MEA Prostate Cancer
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Prostate Cancer Market, By Type
5.1. Introduction
5.2. Global Prostate Cancer Revenue and Market Share by Type (2017-2021)
5.2.1. Global Prostate Cancer Revenue and Revenue Share by Type (2017-2021)
5.3. Benign Prostatic Hyperplasia
5.3.1. Global Benign Prostatic Hyperplasia Revenue and Growth Rate (2017-2021)
5.4. Prostatic Adenocarcinoma
5.4.1. Global Prostatic Adenocarcinoma Revenue and Growth Rate (2017-2021)
5.5. Small Cell Carcinoma
5.5.1. Global Small Cell Carcinoma Revenue and Growth Rate (2017-2021)
5.6. Other Types
5.6.1. Global Other Types Revenue and Growth Rate (2017-2021)
6. Prostate Cancer Market, By Distribution Channel
6.1. Introduction
6.2. Global Prostate Cancer Revenue and Market Share by Distribution Channel (2017-2021)
6.2.1. Global Prostate Cancer Revenue and Revenue Share by Distribution Channel (2017-2021)
6.3. Hospital pharmacies
6.3.1. Global Hospital pharmacies Revenue and Growth Rate (2017-2021)
6.4. Drug stores amp
6.4.1. Global Drug stores amp Revenue and Growth Rate (2017-2021)
6.5. Retail pharmacies
6.5.1. Global Retail pharmacies Revenue and Growth Rate (2017-2021)
6.6. Online pharmacies
6.6.1. Global Online pharmacies Revenue and Growth Rate (2017-2021)
7. Prostate Cancer Market, By Region
7.1. Introduction
7.2. Global Prostate Cancer Revenue and Market Share by Regions
7.2.1. Global Prostate Cancer Revenue by Regions (2017-2021)
7.3. North America Prostate Cancer by Countries
7.3.1. North America Prostate Cancer Revenue and Growth Rate (2017-2021)
7.3.2. North America Prostate Cancer Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Prostate Cancer by Countries
7.4.1. Europe Prostate Cancer Revenue and Growth Rate (2017-2021)
7.4.2. Europe Prostate Cancer Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Prostate Cancer by Countries
7.5.1. Asia-Pacific Prostate Cancer Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Prostate Cancer Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Prostate Cancer by Countries
7.6.1. South America Prostate Cancer Revenue and Growth Rate (2017-2021)
7.6.2. South America Prostate Cancer Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Prostate Cancer by Countries
7.7.1. Middle East and Africa Prostate Cancer Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Prostate Cancer Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Bayer AG
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Johnson & Johnson
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Ipsen Group
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Amgen, Inc.
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Endo Pharmaceuticals, Inc.
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. AbbVie, Inc.
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Pfizer, Inc.
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. AstraZeneca
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Sanofi
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Sanpower Group
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Prostate Cancer Market Forecast (2022-2027)
9.1. Global Prostate Cancer Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Prostate Cancer Market Forecast by Regions (2022-2027)
9.2.1. North America Prostate Cancer Market Forecast (2022-2027)
9.2.1.1. United States Prostate Cancer Market Forecast (2022-2027)
9.2.1.2. Canada Prostate Cancer Market Forecast (2022-2027)
9.2.1.3. Mexico Prostate Cancer Market Forecast (2022-2027)
9.2.2. Europe Prostate Cancer Market Forecast (2022-2027)
9.2.2.1. Germany Prostate Cancer Market Forecast (2022-2027)
9.2.2.2. France Prostate Cancer Market Forecast (2022-2027)
9.2.2.3. UK Prostate Cancer Market Forecast (2022-2027)
9.2.2.4. Russia Prostate Cancer Market Forecast (2022-2027)
9.2.2.5. Italy Prostate Cancer Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Prostate Cancer Market Forecast (2022-2027)
9.2.3. Asia-Pacific Prostate Cancer Market Forecast (2022-2027)
9.2.3.1. China Prostate Cancer Market Forecast (2022-2027)
9.2.3.2. Japan Prostate Cancer Market Forecast (2022-2027)
9.2.3.3. Korea Prostate Cancer Market Forecast (2022-2027)
9.2.3.4. India Prostate Cancer Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Prostate Cancer Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Prostate Cancer Market Forecast (2022-2027)
9.2.4. South America Prostate Cancer Market Forecast (2022-2027)
9.2.4.1. Brazil Prostate Cancer Market Forecast (2022-2027)
9.2.4.2. Argentina Prostate Cancer Market Forecast (2022-2027)
9.2.4.3. Columbia Prostate Cancer Market Forecast (2022-2027)
9.2.4.4. Rest of South America Prostate Cancer Market Forecast (2022-2027)
9.2.5. Middle East and Africa Prostate Cancer Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Prostate Cancer Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Prostate Cancer Market Forecast (2022-2027)
9.2.5.3. Egypt Prostate Cancer Market Forecast (2022-2027)
9.2.5.4. Nigeria Prostate Cancer Market Forecast (2022-2027)
9.2.5.5. South Africa Prostate Cancer Market Forecast (2022-2027)
9.2.5.6. Turkey Prostate Cancer Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Prostate Cancer Market Forecast (2022-2027)
9.3. Prostate Cancer Market Forecast by Type (2022-2027)
9.3.1. Prostate Cancer Forecast by Type (2022-2027)
9.3.2. Prostate Cancer Market Share Forecast by Type (2022-2027)
9.4. Prostate Cancer Market Forecast by Distribution Channel (2022-2027)
9.4.1. Prostate Cancer Forecast by Distribution Channel (2022-2027)
9.4.2. Prostate Cancer Market Share Forecast by Distribution Channel (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Prostate Cancer Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Prostate Cancer Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Prostate Cancer Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Prostate Cancer Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Prostate Cancer Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Prostate Cancer Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Prostate Cancer Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Prostate Cancer Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Prostate Cancer Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Prostate Cancer Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Prostate Cancer Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Prostate Cancer Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Prostate Cancer Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Prostate Cancer Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Prostate Cancer Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Prostate Cancer Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Prostate Cancer Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Prostate Cancer Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Prostate Cancer Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Prostate Cancer Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Prostate Cancer Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Prostate Cancer Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Prostate Cancer Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Prostate Cancer Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Prostate Cancer Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Prostate Cancer Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Prostate Cancer Revenue and Revenue Share by Type (2017-2019)
Figure Global Benign Prostatic Hyperplasia Revenue and Growth Rate (2017-2019)
Figure Global Prostatic Adenocarcinoma Revenue and Growth Rate (2017-2019)
Figure Global Small Cell Carcinoma Revenue and Growth Rate (2017-2019)
Figure Global Other Types Revenue and Growth Rate (2017-2019)
Table Global Prostate Cancer Revenue and Revenue Share by Distribution Channel (2017-2019)
Figure Global Hospital pharmacies Revenue and Growth Rate (2017-2019)
Figure Global Drug stores amp Revenue and Growth Rate (2017-2019)
Figure Global Retail pharmacies Revenue and Growth Rate (2017-2019)
Figure Global Online pharmacies Revenue and Growth Rate (2017-2019)
Table Global Prostate Cancer Revenue by Regions (2017-2019)
Figure North America Prostate Cancer Growth Rate (2017-2019)
Figure North America Prostate Cancer Revenue and Growth Rate (2017-2019)
Figure North America Prostate Cancer by Countries (2017-2019)
Figure North America Prostate Cancer Revenue (Million USD) by Countries (2017-2019)
Figure United States Prostate Cancer Growth Rate (2017-2019)
Figure United States Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Prostate Cancer Growth Rate (2017-2019)
Figure Canada Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Prostate Cancer Growth Rate (2017-2019)
Figure Mexico Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Prostate Cancer Growth Rate (2017-2019)
Figure Europe Prostate Cancer Revenue and Growth Rate (2017-2019)
Figure Europe Prostate Cancer by Countries (2017-2019)
Figure Europe Prostate Cancer Revenue (Million USD) by Countries (2017-2019)
Figure Germany Prostate Cancer Growth Rate (2017-2019)
Figure Germany Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Prostate Cancer Growth Rate (2017-2019)
Figure France Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Prostate Cancer Growth Rate (2017-2019)
Figure UK Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Prostate Cancer Growth Rate (2017-2019)
Figure Russia Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Prostate Cancer Growth Rate (2017-2019)
Figure Italy Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Prostate Cancer Growth Rate (2017-2019)
Figure Rest of Europe Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Prostate Cancer Growth Rate (2017-2019)
Figure Asia-Pacific Prostate Cancer Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Prostate Cancer by Countries (2017-2019)
Figure Asia-Pacific Prostate Cancer Revenue (Million USD) by Countries (2017-2019)
Figure China Prostate Cancer Growth Rate (2017-2019)
Figure China Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Prostate Cancer Growth Rate (2017-2019)
Figure Japan Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Prostate Cancer Growth Rate (2017-2019)
Figure Korea Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Prostate Cancer Growth Rate (2017-2019)
Figure India Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Prostate Cancer Growth Rate (2017-2019)
Figure Southeast Asia Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Prostate Cancer Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Prostate Cancer Growth Rate (2017-2019)
Figure South America Prostate Cancer Revenue and Growth Rate (2017-2019)
Figure South America Prostate Cancer by Countries (2017-2019)
Figure South America Prostate Cancer Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Prostate Cancer Growth Rate (2017-2019)
Figure Brazil Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Prostate Cancer Growth Rate (2017-2019)
Figure Argentina Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Prostate Cancer Growth Rate (2017-2019)
Figure Columbia Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Prostate Cancer Growth Rate (2017-2019)
Figure Rest of South America Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Prostate Cancer Growth Rate (2017-2019)
Figure Middle East and Africa Prostate Cancer Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Prostate Cancer by Countries (2017-2019)
Figure Middle East and Africa Prostate Cancer Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Prostate Cancer Growth Rate (2017-2019)
Figure Saudi Arabia Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Prostate Cancer Growth Rate (2017-2019)
Figure United Arab Emirates Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Prostate Cancer Growth Rate (2017-2019)
Figure Egypt Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Prostate Cancer Growth Rate (2017-2019)
Figure Nigeria Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Prostate Cancer Growth Rate (2017-2019)
Figure South Africa Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Prostate Cancer Growth Rate (2017-2019)
Figure Turkey Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Prostate Cancer Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Prostate Cancer Revenue (Millions USD) and Growth Rate (2017-2019)
Table Bayer AG Prostate Cancer Financial Overview
Table Johnson & Johnson Prostate Cancer Financial Overview
Table Ipsen Group Prostate Cancer Financial Overview
Table Amgen, Inc. Prostate Cancer Financial Overview
Table Endo Pharmaceuticals, Inc. Prostate Cancer Financial Overview
Table AbbVie, Inc. Prostate Cancer Financial Overview
Table Pfizer, Inc. Prostate Cancer Financial Overview
Table AstraZeneca Prostate Cancer Financial Overview
Table Sanofi Prostate Cancer Financial Overview
Table Sanpower Group Prostate Cancer Financial Overview
Figure Global Prostate Cancer Revenue (Millions USD) and Growth Rate (2019-2027)
Table Prostate Cancer Market Forecast by Regions (2019-2027)
Figure North America Prostate Cancer Market Forecast (2019-2027)
Figure United States Prostate Cancer Market Forecast (2019-2027)
Figure Canada Prostate Cancer Market Forecast (2019-2027)
Figure Mexico Prostate Cancer Market Forecast (2019-2027)
Figure Europe Prostate Cancer Market Forecast (2019-2027)
Figure Germany Prostate Cancer Market Forecast (2019-2027)
Figure France Prostate Cancer Market Forecast (2019-2027)
Figure UK Prostate Cancer Market Forecast (2019-2027)
Figure Russia Prostate Cancer Market Forecast (2019-2027)
Figure Italy Prostate Cancer Market Forecast (2019-2027)
Figure Rest of Europe Prostate Cancer Market Forecast (2019-2027)
Figure Asia-Pacific Prostate Cancer Market Forecast (2019-2027)
Figure China Prostate Cancer Market Forecast (2019-2027)
Figure Japan Prostate Cancer Market Forecast (2019-2027)
Figure Korea Prostate Cancer Market Forecast (2019-2027)
Figure India Prostate Cancer Market Forecast (2019-2027)
Figure Southeast Asia Prostate Cancer Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Prostate Cancer Market Forecast (2019-2027)
Figure South America Prostate Cancer Market Forecast (2019-2027)
Figure Brazil Prostate Cancer Market Forecast (2019-2027)
Figure Argentina Prostate Cancer Market Forecast (2019-2027)
Figure Columbia Prostate Cancer Market Forecast (2019-2027)
Figure Rest of South America Prostate Cancer Market Forecast (2019-2027)
Figure Middle East and Africa Prostate Cancer Market Forecast (2019-2027)
Figure Saudi Arabia Prostate Cancer Market Forecast (2019-2027)
Figure United Arab Emirates Prostate Cancer Market Forecast (2019-2027)
Figure Egypt Prostate Cancer Market Forecast (2019-2027)
Figure Nigeria Prostate Cancer Market Forecast (2019-2027)
Figure South Africa Prostate Cancer Market Forecast (2019-2027)
Figure Turkey Prostate Cancer Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Prostate Cancer Market Forecast (2019-2027)
Figure Global Prostate Cancer Forecast by Type (2019-2027)
Figure Global Prostate Cancer Market Share Forecast by Type (2019-2027)
Figure Global Prostate Cancer Forecast by Type (2019-2027)
Figure Global Prostate Cancer Forecast by Distribution Channel (2019-2027)
Figure Global Prostate Cancer Market Share Forecast by Distribution Channel (2019-2027)
Figure Global Prostate Cancer Forecast by Distribution Channel (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|